Ascend Wellness Holdings, Inc. (AAWH)
(Delayed Data from OTC)
$1.30 USD
-0.06 (-4.41%)
Updated May 17, 2024 03:59 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
AAWH 1.30 -0.06(-4.41%)
Will AAWH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AAWH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AAWH
Ascend Wellness Holdings, Inc. (AAWH) Reports Q1 Loss, Tops Revenue Estimates
Analysts Estimate Sharecare, Inc. (SHCR) to Report a Decline in Earnings: What to Look Out for
AAWH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Ascend Wellness Holdings, Inc. (AAWH) Report Negative Earnings Next Week? What You Should Know
Sotera Health Company (SHC) Meets Q4 Earnings Estimates
Here Is Why Bargain Hunters Would Love Fast-paced Mover Ascend Wellness Holdings, Inc. (AAWH)
Other News for AAWH
DoJ proposed cannabis rescheduling rule says DEA still hasn't weighed in
MJUS: Big Implications As President Biden Reschedules Cannabis
Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M
Cannabis rescheduling unlikely to happen by end of year -- Seeking Alpha survey
Marijuana THC potency at all-time high - DEA